Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2024

Authors

  • Monica M Lahra World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW, 2052, Australia
  • Sonya Natasha Hutabarat World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia
  • Tiffany R Hogan World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia

DOI:

https://doi.org/10.33321/cdi.2025.49.008

Keywords:

antimicrobial resistance, disease surveillance, meningococcal disease, Neisseria meningitis

Abstract

This report, as originally published, contained numerical errors in the report’s Table 1, inadvertently misrepresenting the second-quarter (Q2) and year-to-date (ytd) totals for invasive meningococcal disease reported from Victoria in 2023. The revised table presented overleaf corrects these errors.

Downloads

Download data is not yet available.

Downloads

Published

22/01/25

How to Cite

Lahra, Monica M, Sonya Natasha Hutabarat, and Tiffany R Hogan. 2025. “Meningococcal Surveillance Australia Reporting Period 1 April to 30 June 2024”. Communicable Diseases Intelligence 49 (January). https://doi.org/10.33321/cdi.2025.49.008.

Most read articles by the same author(s)

<< < 5 6 7 8 9 10 11 12 > >>